Stem Cells http://www.stemcellsportal.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bray, S. E.
Right arrow Articles by Hall, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bray, S. E.
Right arrow Articles by Hall, P. A.
Stem Cells, Vol. 16, No. 4, 248-260, July 1998
© 1998 AlphaMed Press


Concise Reviews

The Challenge of p53: Linking Biochemistry, Biology, and Patient Management

Susan E. Bray, Christoph Schorl, Peter A. Hall

Department of Cellular and Molecular Pathology, University of Dundee, Ninewells Hospital and Medical School, Dundee, Scotland, UK

Key Words. p53 • Stress responses • Physiology • Biochemistry • Therapy

Dr. Peter A. Hall, Department of Cellular and Molecular Pathology, University of Dundee, Ninewells Hospital and Medical School, Dundee, DD1 9SY, Scotland, UK.

Abnormalities of the p53 tumor suppressor gene are the single most common molecular abnormality seen in human cancer. Considerable evidence indicates that the product of this gene has critical roles in coordinating the response of cells to a diverse range of environmental stresses. At present, there is a gamut of biochemical properties and interactions ascribed to p53, but the in vivo physiological relevance of many of these remains uncertain. The development of clinical applications and novel therapeutic strategies utilizing our knowledge of p53 is contingent upon bridging the gap between rigorous biochemistry and holistic in vivo studies.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
P. A. Hall, S. J. Campbell, M. O'neill, D. J. Royston, K. Nylander, F. A. Carey, and N. M. Kernohan
Expression of the p53 homologue p63{alpha} and {Delta}Np63{alpha} in normal and neoplasticcells
Carcinogenesis, February 1, 2000; 21(2): 153 - 160.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
P. A. Hall
p53: The Challenge of Linking Basic Science and Patient Management
Oncologist, August 1, 1998; 3(4): 218 - 224.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
Email Content Delivery
Copyright © 1998 by AlphaMed Press.